Authors,Title,Year,Source title,Volume,Issue,Art. No.,Page start,Page end,Page count,Cited by,DOI,Link,Document Type,Source,EID
"Antonarakis, E.S., Scher, H.I.","Do Patients With AR-V7–Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions",2017,"European Urology","71","1",,"4","6",,3,10.1016/j.eururo.2016.08.038,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85002744038&doi=10.1016%2fj.eururo.2016.08.038&partnerID=40&md5=f88c3d6e220681ccdc357cde70837094",Editorial,Scopus,2-s2.0-85002744038
"Wilkerson, J., Abdallah, K., Hugh-Jones, C., Curt, G., Rothenberg, M., Simantov, R., Murphy, M., Morrell, J., Beetsch, J., Sargent, D.J., Scher, H.I., Lebowitz, P., Simon, R., Stein, W.D., Bates, S.E., Fojo, T.","Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis",2017,"The Lancet Oncology","18","1",,"143","154",,3,10.1016/S1470-2045(16)30633-7,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007478332&doi=10.1016%2fS1470-2045%2816%2930633-7&partnerID=40&md5=def5ac44f7720c0e6986539fe4e5fede",Article,Scopus,2-s2.0-85007478332
"Chi, K.N., Kheoh, T., Ryan, C.J., Molina, A., Bellmunt, J., Vogelzang, N.J., Rathkopf, D.E., Fizazi, K., Kantoff, P.W., Li, J., Azad, A.A., Eigl, B.J., Heng, D.Y.C., Joshua, A.M., de Bono, J.S., Scher, H.I.","A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel",2016,"Annals of Oncology","27","3", mdv594,"454","460",,14,10.1093/annonc/mdv594,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959912648&doi=10.1093%2fannonc%2fmdv594&partnerID=40&md5=c6c959a16adb5fcfc657e83b46270646",Article,Scopus,2-s2.0-84959912648
"Scher, H.I., Heller, G., Molina, A., Kheoh, T., De Bono, J.S.","Reply to A. Addeo and A. Bahl",2016,"Journal of Clinical Oncology","34","4",,"387","",,,10.1200/JCO.2015.64.6562,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955468891&doi=10.1200%2fJCO.2015.64.6562&partnerID=40&md5=b358eb96242efe8de4de23f71fd5596a",Letter,Scopus,2-s2.0-84955468891
"Teo, M.Y., Scher, H.I.","Urological cancer: CHAARTED/GETUG 12-docetaxel in non-castrate prostate cancers",2015,"Nature Reviews Clinical Oncology","12","12",,"687","688",,,10.1038/nrclinonc.2015.192,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84948385502&doi=10.1038%2fnrclinonc.2015.192&partnerID=40&md5=836fe6cdeff627c724b5ccfd68cfe302",Short Survey,Scopus,2-s2.0-84948385502
"Scher, H.I.","Building on Prostate Cancer Working Group 2 to change the paradigm from palliation to cure",2014,"American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting",,,,"e204","e212",,1,10.14694/EdBook_AM.2014.34.e204,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84948098992&doi=10.14694%2fEdBook_AM.2014.34.e204&partnerID=40&md5=56b1cb0249c3b1cd8018dca443b25e2e",Review,Scopus,2-s2.0-84948098992
"Morris, M.J., Tong, W.P., Cordon-Cardo, C., Drobnjak, M., Kelly, W.K., Slovin, S.F., Terry, K.L., Siedlecki, K., Swanson, P., Rosen, N., Scher, H.I., Morris, M.J., Tong, W.P., Cordon-Cardo, C., Drobnjak, M., Kelly, W.K., Slovin, S.F., Swanson, P., Rosen, N., Scher, H.I., Rafi, M., DiPaola, R.S.","Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer",2002,"Clinical Cancer Research","8","3",,"679","683",,167,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036303535&partnerID=40&md5=3afcaa09b8abaed49eb5398027beec8c",Article,Scopus,2-s2.0-0036303535
